124 related articles for article (PubMed ID: 25145319)
1. An aptamer intrinsically comprising 5-fluoro-2'-deoxyuridine for targeted chemotherapy.
Kruspe S; Hahn U
Angew Chem Int Ed Engl; 2014 Sep; 53(39):10541-4. PubMed ID: 25145319
[TBL] [Abstract][Full Text] [Related]
2. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
[TBL] [Abstract][Full Text] [Related]
3. Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cells.
Lee KY; Kang H; Ryu SH; Lee DS; Lee JH; Kim S
J Biomed Biotechnol; 2010; 2010():168306. PubMed ID: 20204158
[TBL] [Abstract][Full Text] [Related]
4. ALPPL2 Aptamer-Mediated Targeted Delivery of 5-Fluoro-2'-Deoxyuridine to Pancreatic Cancer.
Dua P; S S; Kim S; Lee DK
Nucleic Acid Ther; 2015 Aug; 25(4):180-7. PubMed ID: 25919296
[TBL] [Abstract][Full Text] [Related]
5. A polyvalent aptamer system for targeted drug delivery.
Zhang Z; Ali MM; Eckert MA; Kang DK; Chen YY; Sender LS; Fruman DA; Zhao W
Biomaterials; 2013 Dec; 34(37):9728-35. PubMed ID: 24044994
[TBL] [Abstract][Full Text] [Related]
6. Charomers-Interleukin-6 Receptor Specific Aptamers for Cellular Internalization and Targeted Drug Delivery.
Hahn U
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211023
[TBL] [Abstract][Full Text] [Related]
7. Impact of the Position of the Chemically Modified 5-Furyl-2'-Deoxyuridine Nucleoside on the Thrombin DNA Aptamer-Protein Complex: Structural Insights into Aptamer Response from MD Simulations.
Seelam Prabhakar P; A Manderville R; D Wetmore S
Molecules; 2019 Aug; 24(16):. PubMed ID: 31405145
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-based tumor-targeted drug delivery for photodynamic therapy.
Shieh YA; Yang SJ; Wei MF; Shieh MJ
ACS Nano; 2010 Mar; 4(3):1433-42. PubMed ID: 20166743
[TBL] [Abstract][Full Text] [Related]
9. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
Zhu H; Li J; Zhang XB; Ye M; Tan W
ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
[TBL] [Abstract][Full Text] [Related]
10. A Molecular Recognition Approach To Synthesize Nucleoside Analogue Based Multifunctional Nanoparticles for Targeted Cancer Therapy.
Wang D; Liu B; Ma Y; Wu C; Mou Q; Deng H; Wang R; Yan D; Zhang C; Zhu X
J Am Chem Soc; 2017 Oct; 139(40):14021-14024. PubMed ID: 28945366
[TBL] [Abstract][Full Text] [Related]
11. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy.
Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S
Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950
[TBL] [Abstract][Full Text] [Related]
12. Parallel G-quadruplex Structures Increase Cellular Uptake and Cytotoxicity of 5-Fluoro-2'-deoxyuridine Oligomers in 5-Fluorouracil Resistant Cells.
Clua A; Fàbrega C; García-Chica J; Grijalvo S; Eritja R
Molecules; 2021 Mar; 26(6):. PubMed ID: 33804620
[TBL] [Abstract][Full Text] [Related]
13. Application of aptamers for targeted therapeutics.
Ray P; Viles KD; Soule EE; Woodruff RS
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
[TBL] [Abstract][Full Text] [Related]
14. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
[TBL] [Abstract][Full Text] [Related]
15. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
16. Aptamers Entirely Built from Therapeutic Nucleoside Analogues for Targeted Cancer Therapy.
Zhu L; Yang J; Ma Y; Zhu X; Zhang C
J Am Chem Soc; 2022 Feb; 144(4):1493-1497. PubMed ID: 35073490
[TBL] [Abstract][Full Text] [Related]
17. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
He X; Hai L; Su J; Wang K; Wu X
Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
[TBL] [Abstract][Full Text] [Related]
18. Structural requirement of G-quadruplex/aptamer-combined DNA macromolecule serving as efficient drug carrier for cancer-targeted drug delivery.
Li C; Wu B; Chen S; Hao K; Yang J; Cao H; Yang S; Wu ZS; Shen Z
Eur J Pharm Biopharm; 2021 Feb; 159():221-227. PubMed ID: 33253890
[TBL] [Abstract][Full Text] [Related]
19. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
Taghdisi SM; Lavaee P; Ramezani M; Abnous K
Eur J Pharm Biopharm; 2011 Feb; 77(2):200-6. PubMed ID: 21168488
[TBL] [Abstract][Full Text] [Related]
20. Discovery of an Orally Active and Liver-Targeted Prodrug of 5-Fluoro-2'-Deoxyuridine for the Treatment of Hepatocellular Carcinoma.
Peng Y; Yu W; Li E; Kang J; Wang Y; Yang Q; Liu B; Zhang J; Li L; Wu J; Jiang J; Wang Q; Chang J
J Med Chem; 2016 Apr; 59(8):3661-70. PubMed ID: 27022837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
